Stefania Pittaluga, M.D., Ph.D.
Dr. Pittaluga’s research interests are concerned with the molecular pathogenesis of lymphomas and the characterization of primary immunodeficiency disorders.
1) hematopathology, 2) lymphomas, 3) primary immunodeficiency, 4) in-situ hybridization
Center for Cancer Research
National Cancer Institute
Building 10, Room 2S235A
Bethesda, MD 20892-1500
Dr. Pittaluga’s research focuses on the molecular pathogenesis of lymphomas and the characterization of primary immunodeficiency disorders.
Selected Recent Publications
Pulmonary Manifestations of the Autoimmune Lymphoproliferative Syndrome. A Retrospective Study of a Unique Patient Cohort..Ann Am Thorac Soc. 13(8): 1279-88, 2016. [ Journal Article ]
- Oncotarget. 7(28): 43052-43061, 2016. [ Journal Article ]
Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion.Hum Pathol. 55: 108-16, 2016. [ Journal Article ]
Immune-checkpoint expression in Epstein-Barr virus positive and negative plasmablastic lymphoma: a clinical and pathological study in 82 patients.Haematologica. 101(8): 976-84, 2016. [ Journal Article ]
Association of GATA2 Deficiency With Severe Primary Epstein-Barr Virus (EBV) Infection and EBV-associated Cancers.Clin Infect Dis. 63(1): 41-7, 2016. [ Journal Article ]
Dr. Pittaluga received her M.D. from the University of Sassari (Italy) and her Ph.D. in medical sciences from the Catholic University of Leuven (Belgium). She completed her clinical training in anatomic pathology at the Hebrew University Hadassah Medical School in Jerusalem (Israel) and at the National Cancer Institute (NCI) in Bethesda, Maryland. She also completed a fellowship in hematopathology at the NCI. She has been a staff clinician in the Hematopathology Section since 1999 and Program Director of the Hematopathology Fellowship program at the NIH/NCI since 2005. As Program Director, she is an active member of the Graduate Medical Education Committee (GMEC) and past Chair.
Dr. Pittaluga has been recognized for research excellence by the NCI, the National Heart Lung and Blood Institute (NHLBI) and the National Institute of Allergy and Infectious Diseases (NIAID). She is a past member of the Scientific Committee on Hematopathology and Clinical Laboratory Hematology for the American Society of Hematology.